B-cell Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2025-11-25
EMA Authorised: Zynlonta (loncastuximab tesirine) — Swedish Orphan Biovitrum AB
The European Medicines Agency authorized Zynlonta (loncastuximab tesirine) for diffuse large B-cell lymphoma and B-cell lymphoma, under a co…